Skip to content Skip to sidebar Skip to footer

SENTRIAN NAMED A FINALIST IN FIERCE INNOVATION AWARDS: HEALTHCARE EDITION

ALISO VIEJO, Calif., Nov. 19, 2015 /PRNewswire/ — Sentrian, the Remote Patient Intelligence™ company aspiring to eliminate all preventable hospitalization, has been selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher of FierceHealthIT, FierceHealthcare, and FierceMobileHealthcare.Sentrian was recognized as a finalist in the category of Digital/Mobile…

Read more

FROST & SULLIVAN COMMENDS SENTRIAN FOR DEVELOPING AN ANALYTICS-BASED SOLUTION THAT WILL AID THE WIDER ADOPTION OF REMOTE PATIENT MONITORING

Sentrian expected to transform RPM from a basic report-and-flag model to an evolving analytical response solution that detects health deterioration earlier and with higher accuracy MOUNTAIN VIEW, Calif., Oct. 6, 2015 /PRNewswire/ — Based on its recent analysis of the remote patient monitoring (RPM) market, Frost & Sullivan recognizes Sentrian with the 2015 North American Frost & Sullivan…

Read more

FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution

ALISO VIEJO, Calif., July 30, 2015 /PRNewswire/ -- Sentrian, the Remote Patient Intelligence™ company aspiring to eliminate all preventable hospitalization, recently received confirmation from the Food & Drug Administration (FDA) that its Remote Patient Intelligence (RPI) solution meets the definition of a "medical device" for which the FDA intends to exercise "Enforcement Discretion." The designation identifies medical devices…

Read more